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Background: A Saururus chinensis Baill (SC) has been used by Native Americans, early colonists and practitioners
of Korean traditional medicine for treating several diseases including cancer, rheumatoid arthritis and edema.
The objective of this study was to evaluate the effects of SC extract in lipopolysaccharide (LPS)-stimulated
neuroinflammatory responses in BV-2 microglial cells.
Methods: The effects of SC on the LPS–induced neuroinflammatory responses in BV-2 microglial cells were assessed
by Western blotting, RT-PCR and immunofluorescence labeling techniques. DPPH and alkyl radical scavenging assay
was performed to evaluate the anti-oxidant effects. Comparisons between groups were analyzed using one-way
analysis of variance followed by Dunnett’s multiple comparisons test using GraphPad Prism V5.01 software.
Results: Pre-treatment with SC extract (1, 5 and 10 μg/mL) significantly (p < 0.001 at 10 μg/mL) and concentration
dependently inhibited LPS-induced production of nitric oxide (NO), inducible NO synthase (iNOS), cyclooxygenase-2
(COX-2) and suppressed the inflammatory cytokine levels such as tumor necrosis factor-alpha and interleukin (IL)-6 in
BV-2 microglial cells (p < 0.001 at 10 μg/mL). Further, SC suppressed the nuclear factor-kappa B (NF-κB) activation by
blocking the degradation of IκB-α. SC also exhibited profound anti-oxidant effects by scavenging 1, 1-diphenyl-2-
picrylhydrazyl (DPPH) (IC50: 0.055 mg/mL) and alkyl radicals (IC50: 0.349 mg/mL). High performance liquid
chromatography finger printing analysis of SC revealed quercetin (QCT) as one of the major constituents compared
with reference standard. QCT also inhibited the excessive release of NO, and inhibited the increased expressional levels
of IL-6, iNOS and COX-2 in LPS-stimulated BV-2 cells.
Conclusions: Our results indicated that SC inhibited the LPS-stimulated neuroinflammatory responses in BV-2
microglia via regulation of NF-κB signaling. The antioxidant active constituents of SC might be partly involved in
delivering such effects. Based on the traditional claims and our present results SC can be potentially used in treating
inflammatory-mediated neurodegenerative diseases.
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Microglia, the immune cells of the central nervous system
(CNS), plays an important role in neuroinflammation. It
was well documented that microglial activation increases
the risk for several CNS diseases such as Alzheimer’s
disease, Parkinson’s disease (PD), multiple sclerosis, and
Huntington’s disease [1-4]. Excessive activation of microglia
due to pathogenic bacterial infection or injury releases
proinflammatory mediators such as tumor necrosis factor
(TNF)-α, interleukin (IL)-1β, IL-6, reactive oxygen species
(ROS), nitric oxide (NO), inducible NO synthase (iNOS)
and cyclooxygenase (COX)-2 [5]. Therefore, attenuation of
neuroinflammatory events in microglia might be a promis-
ing strategy for preventing the progression of inflamma-
tory-mediated neurodegenerative diseases.
Saururus chinensis Baill. (SC), a fragrant aquatic plant
from the family Saururaceae has been used by Native
Americans, early colonists and practitioners of Korean
traditional medicine for treating a range of diseases
including cancer, rheumatoid arthritis and nephritis-
associated edema [6]. Pharmacological reports showed
that SC possess anti-asthmatic [7,8], anti-oxidative [9-11],
anti-angiogenic [12], anti-inflammatory [7,10,12], anti-
atopic [13], anti-cancer [14] and hepatoprotective proper-
ties [15]. Based on these reports, complementary studies
are needed to determine whether the beneficial effects of
SC are applicable to the treatment of neuroinflammatory
and neurodegenerative diseases. In the present study, we
investigated the anti-neuroinflammatory effects of SC
extract against LPS-stimulated BV-2 microglial cells and
explored the underlying mechanisms. The antioxidant
status of SC was also evaluated using in vitro free
radical scavenging assays. Further, to identify the major
constituents in SC extract used in the study, high
performance liquid chromatography (HPLC) finger-
printing analysis was performed.
Methods
Chemical materials
Lipopolysaccharide (LPS) (E. coli 0111:B4), Tween20,
bovine serum albumin (BSA), dimethyl sulfoxide (DMSO),
3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium brom-
ide (MTT) and quercetin (QCT) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Six-well and 96-well
tissue culture plates and 100 mm culture dishes were pur-
chased from Nunc Inc. (North Aurora, IL, USA). DMEM
containing 4.5 g/L D-glucose, L-arginine, 110 mg/L sodium
pyruvate, and fetal bovine serum, as well as other
cell culture reagents, TRIZOL and a Superscript™-III
kit were obtained from Gibco/Invitrogen (Carlsbad,
CA, USA). The 10× RIPA buffer was purchased from
Millipore (Milford, MA, USA). The protease inhibitor
cocktail tablets, phosphatase inhibitor cocktail tablets were
supplied by Roche (Indianapolis, IN, USA). Antibodiesto nuclear factor (NF)-κB p65 and COX-2 were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Antibodies for iNOS, IκB-α, phosphor (p)-IκB-α, and
β-actin were supplied by Cell Signaling Technology
(Danvers, MA, USA).
Preparation of the SC extract
Dried SC root material was purchased from a traditional
herb market in Korea and authenticated by a taxonomist at
the Plant Extract Bank, South Korea. A voucher specimen
(CA02-047) was deposited at the institute’s herbarium,
Konkuk University. To obtain the ethanol extract, 100 g of
dried root material was added to 1 L of 95% ethanol, and
the extraction was performed with sonication at room
temperature for 15 min with an interval of 2 h using a
40 kHz model 8210R ultrasonic reactor (Branson Ultra-
sonic, Corp. Newtown, CT, USA). The procedure was re-
peated 15 times, and the mixture was filtered with 0.22 μM
type GV film (Millipore, Milford, MA, USA). The filtrate
was combined, and the final product was concentrated with
a rotary evaporator, lyophilized, and stored at 4°C. The
resulting powder (yield, 14.4 g) was re-dissolved in DMSO
(0.1%) and filtered through a 0.22 μM filter before use.
Standard QCT was purchased from Sigma-Aldrich for the
comparative experimental studies. The SC extract and
QCT were subjected to analytical HPLC (Waters, Sudbury,
ONT, Canada), equipped with a UV detector. A GROM-
SIL 120 C18 (4.0 mm× 250 mm) column was used.
High-performance liquid chromatography (HPLC) finger
print analysis
A Waters liquid chromatography system (Waters Asso-
ciates Inc., Bedford, MA, USA), equipped with a double
pump and a photodiode array detector was used. Separ-
ation was carried out on a Cosmosil 5C18-AR-II column
(4.6 mm× 250 mm, 5 μm) with a column temperature set
to 25°C. The mobile phases consisted of 0.4% aqueous
phosphoric acid (A) and acetonitrile (B). For gradient
elution the conditions were: 15% B (v/v) at 0–16 min,
15–25% B at 16–30 min, 25% B at 30–32 min, 25–30% B
at 32–35 min, 30% B at 35–37 min, 30–33% B at 37–
40 min, 33% B at 40–45 min, 33–48% B at 45–55 min,
48–55% B at 55–75 min, 55–80% B at 75–82 min, 80% B
at 82–88 min, and the re-equilibration time of the gradient
elution was 15 min. Flow rate was 0.8 mL/min, and in-
jection volume was 10 μL. The detection wavelength for
the QCT analyte was set to 360 nm. The absorption
spectrum of the compound was recorded at 200–500 nm.
The compound was identified by comparing the retention
time and UV spectrum with those of standard markers.
Cell culture and viability assay
BV-2 microglial cells were obtained and cultured as
described previously [16]. Briefly, cells were seeded at a
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ous concentrations of SC (1, 5, and 10 μg/mL) and then
incubated for 24 h in medium containing LPS (100 ng/mL).
Then, 0.5 mg/mL MTT was added to each well. After 4 h
incubation at 37°C and 5% CO2, the supernatants were
removed from each well, and the formed formazan crys-
tals in the viable cells were dissolved in DMSO. Absorb-
ance was determined at 540 nm using a microplate
reader (Tecan Trading AG, Basel, Switzerland).
NO production assay
NO production was assayed by measuring the levels of
nitrite in culture medium using a colorimetric assay with
Griess reagent [17]. BV-2 cells (5 × 104 cells/mL) were
seeded in 96-well plates in 100 μL culture medium and
stimulated with LPS (100 ng/mL) for 24 h. The culture
supernatant (50 μL) was reacted with an equal volume
of Griess reagent (0.1% naphthylethylenediamine and 1%
sulfanilamide in 5% H3PO4) in 96-well plates for 10 min
at room temperature in the dark. Nitrite concentrations
were determined using standard sodium nitrite solutions
prepared in medium. The absorbance was determined at
540 nm using a microplate reader.
Isolation of total RNA and reverse transcription
polymerase chain reaction (RT-PCR)
Total RNA was extracted using TRIZOL reagent accord-
ing to the manufacturer’s instructions. RNA (2.5 μg) was
reverse-transcribed using a Superscript™-III kit according
to the manufacturer’s instruction. PCR amplification
was conducted using specific primers sets at annealing
temperatures of 53.5–58°C for 20–30 cycles. The primer
sequences used are presented in Table 1. The PCR con-
ditions were described previously [18].
Western blot analysis
Cells were washed twice with PBS, placed at 4°C, and lysed
for 10 min in lysis buffer (1× RIPA lysis buffer, protease
inhibitor cocktail, phosphatase inhibitor cocktail). LysatesTable 1 PCR primers used















Rwere centrifuged at 14000 rpm and 4°C, and the superna-
tants were collected for further analysis. Equal amounts of
protein (40 μg) were separated electrophoretically by 10%
sodium dodecyl sulfate-polyacrylamide electrophoresis,
and the resolved proteins were transferred to polyvinyli-
dene difluoride membranes (Millipore). The membranes
were incubated for 1 h with 5% BSA in TPBT buffer to
block nonspecific binding. The membranes were then in-
cubated with primary antibodies to anti-iNOS, anti-IκB-α,
anti-phospho-IκB-α (1:1000; Cell Signaling Technology),
anti-β-actin (1:2000; Cell Signaling Technology) and anti-
COX-2 (1:1000; Santa Cruz Biotechnology). The blots
were visualized using PowerOpti-ECL (Animal Genetics
Inc, Tallahassee, FL, USA) detection system according
to the manufacturer’s procedure. Antibody-specific bands
were scanned using a LAS-3000 luminescent analyzer,
and quantified using Fuji Multigauge software V3.1 (Fuji,
Tokyo, Japan).
Double-immunofluorescence labeling assay
BV-2 microglia cells (1 × 105 cells/well in a 12-well plate)
were cultured on sterile cover slips in 12-well plates and
treated with compounds and LPS to detect the intracel-
lular location of the NF-κB p65 subunit. At 30 min after
LPS treatment, the cells were fixed with methanol for
20 min at -20°C and washed three times with PBS. The
fixed cells were then permeabilized with 1% Triton X-
100 in PBS for 10 min at room temperature (RT),
washed with 0.05% Tween20 in PBS for 5 min, followed
by 0.05% Tween20/1% BSA in PBS for 5 min. The
permeabilized cells were then treated with anti-NF-κB
p65 (1:200; Santa Cruz Biotechnology) overnight at 4°C
and washed with 0.05% Tween20/1% BSA in PBS for
5 min. The cells were then incubated in a 1:100 dilution
of Alexa Fluor 568-labeled goat anti-mouse antibody
(Invitrogen, Carlsbad, CA, USA) for 1 h at RT and
washed with 0.05% Tween20 in PBS for 5 min, followed
by PBS for 5 min. The cells were then stained with 1 μM
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a Carl Zeiss Axio 40 fluorescence microscope (Carl Zeiss,
Oberkochen, Germany).
Measurement of free radical scavenging activity
Free radical scavenging activity was evaluated using an
electron spin resonance (ESR) spectrometer (JEOL, Tokyo,
Japan). DPPH radical scavenging activity was measured
using a method described previously [19]. A sample solu-
tion of SC (30 μL) was added to 60 μM DPPH (30 μL) in
methanol and incubated for 2 min. Alkyl radicals were
generated by 2,2′-azobis (2-amidinopropane) hydrochlor-
ide (AAPH). The reaction mixture containing 10 mM
AAPH (20 μL), 10 mM 4-POBN (20 μL), and SC (20 μL)
of various concentrations in PBS (20 μL, pH 7.4) was
incubated at 37°C in a water bath for 30 min. The ESR
spectrum was recorded for each radical using an ESR
spectrometer.
Statistical analysis
Data are expressed as means ± standard errors of mean
(S.E.M). Each value was the result of three independent
experiments (n = 3). Comparisons between groups were
analyzed using one-way analysis of variance followed by
Dunnett’s multiple comparisons test using GraphPad
Prism V5.01 software (GraphPad Software Inc., San Diego,
CA, USA). P-values < 0.05 were considered significant.
Results
SC extract attenuated LPS-induced nitrite production in
BV-2 microglial cells
To determine the cytotoxic potential of the SC extract,
we evaluated its effects on the viability of BV-2 micro-
glial cells at 5 × 104 cells/mL. The MTT assay was per-
formed 24 h after treatment with various concentrations
(1–10 μg/mL) of SC in the presence or absence of LPS
(100 ng/mL). Treatment with SC alone or with LPS
(100 ng/mL) did not result in any signs of cytotoxicity atFigure 1 Effect of the SC extract on nitrite production in LPS-stimulat
the MTT assay (A). Cells were incubated with 1, 5, and 10 μg/mL of SC and
control samples. Nitrite in the medium was determined by the Griess assay
Data are mean ± standard error (n = 3) of three independent experiments.
compared with LPS-treated group. SC: Saururus chinensis, LPS: lipopolysaccharthe indicated concentrations (Figure 1A). The vehicle
(0.1% DMSO) used to dissolve SC also did not show any
effect on overall cell viability as determined by the MTT
assay (data not shown). To evaluate the effect of SC on
NO production, BV-2 microglia cells were pretreated with
1, 5, and 10 μg/mL SC for 1 h and then stimulated with
LPS (100 ng/mL). The culture medium from the cells was
harvested and assayed for NO generation. Stimulation
with LPS significantly increased (p < 0.001) the release of
NO compared with that in the control group (Figure 1B).
However, pretreatment with SC (1, 5, and 10 μg/mL)
inhibited NO release in LPS-stimulated BV-2 cells in a
concentration-dependent manner (Figure 1B).
SC suppressed LPS-induced iNOS and COX-2 expression
in BV-2 microglia cells
As shown in Figure 2A and Figure 2B, treatment with
LPS increased iNOS mRNA expression at 6 h and iNOS
protein expression at 18 h, respectively (p < 0.001). How-
ever, pretreatment with SC significantly attenuated LPS-
induced iNOS mRNA and iNOS protein expression.
These data indicate that SC suppresses LPS-induced NO
production by inhibiting iNOS expression. COX-2 mRNA
and protein levels were also significantly suppressed by SC
in LPS-stimulated BV-2 cells. As shown in Figure 2C and
Figure 2D, LPS treatment significantly up regulated COX-
2 mRNA and protein expression. However, pretreatment
with SC (1, 5, and 10 μg/mL) significantly (p < 0.01 at
5 μg/mL and p < 0.001 at 10 μg/mL) and concentration
dependently reduced this increase in LPS-stimulated BV-2
cells. These data correlated well with the reduction in pro-
tein and corresponding mRNA levels.
SC extract inhibited LPS-induced TNF-α and IL-6 production
in BV-2 microglial cells
Proinflammatory cytokines such as TNF-α, IL-1β, and
IL-6 are stimulators and/or co-stimulators of iNOS gene
expression and play major roles in inflammatory diseaseed BV-2 microglia. Viability in SC-treated cells was evaluated using
LPS (100 ng/mL) for 24 h. Results are displayed as a percentage of
(B). Results are displayed as a percentage of the LPS treated group.
$p < 0.001, compared with control group; *p < 0.05 and ***p < 0.001
ide, MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide.
Figure 2 Inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 mRNA and protein expression by the SC
extract in LPS-stimulated BV-2 microglia. (A, C) Cells were pretreated with the indicated concentrations of SC (1, 5, and 10 μg/ml) 1 h before
stimulation for 6 h with 100 ng/mL LPS. Total RNA was prepared for reverse transcription-polymerase chain reaction analysis of iNOS and COX-2
gene expression from LPS-stimulated BV-2 microglia. (B, D) Cell lysates were electrophoresed, and iNOS and COX-2 expression was detected by a
specific antibody. Data are mean ± standard error (n = 3) for three independent experiments. $p < 0.001, compared with control group; **p < 0.01
and ***p < 0.001 compared with LPS-treated group. SC: Saururus chinensis, LPS: Lipopolysaccharide.
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effect on the production of proinflammatory cytokines
(TNF-α and IL-6), BV-2 microglia were stimulated with
LPS (100 ng/mL) in the presence or absence of SC at
the indicated concentrations (1, 5 and 10 μg/mL). RT-
PCR analysis showed that the mRNA levels of these
cytokines increased 6 h after LPS treatment (p < 0.001).
Pretreatment with SC for 1 h attenuated the upregula-
tion of TNF-α and IL-6 in a concentration-dependent
manner (Figure 3A and Figure 3B). These data suggest
that SC inhibits the production of TNF-α and IL-6 by
mediating regulatory gene expression at the transcrip-
tional level, which is involved in the microglia-mediated
inflammatory process.
SC regulated NF-κB activation in LPS-induced BV-2
microglial cells
A previous study reported that LPS increases activation
of the NF-κB subunit (via phosphorylation, ubiquitina-
tion, degradation and translocation of p65 and IκB-a)
and regulates the expression of iNOS, COX-2, and other
pro-inflammatory cytokines [22,23]. Therefore, we per-
formed double-immunofluorescence labeling assay studiesto investigate whether the SC extract inhibited NF-κB
translocation in LPS-stimulated BV-2 microglial cells.
Interestingly, SC blocked nuclear translocation of the NF-
κB p65 subunit (Figure 4A). To evaluate the effect of SC
on IκB-α phosphorylation, BV-2 microglia were pretreated
with SC (1, 5, and 10 μg/mL) for 1 h and then stimulated
with LPS (100 ng/mL) for 30 min. IκB-α phosphorylation
increased significantly (p < 0.001) after LPS treatment and
translocation of the NF-κB p65 subunit was induced into
the nucleus. SC pretreatment suppressed IκB-α phosphor-
ylation in a concentration-dependent manner (Figure 4B
and Figure 4C). These data demonstrate that SC inhibits
NF-κB activation in LPS-stimulated BV-2 microglia and
that this mechanism may contribute to the regulation of
neuroinflammatory events.
Free radical scavenging activities of SC
The potential of the SC extract to quench free radicals
such as DPPH and alkyl radicals was investigated. DPPH
is a stable free radical that accepts an electron or hydro-
gen radical to become a stable diamagnetic molecule.
DPPH has been used to evaluate free radical scavenging
activity of natural antioxidants. The capacity of SC to
Figure 3 Effect of the SC extract on pro-inflammatory cytokines in LPS-stimulated BV-2 microglia. Cells were pretreated with the
indicated concentrations of SC for 1 h before LPS (100 ng/mL) treatment. After incubation with LPS for 6 h, tumor necrosis factor (TNF)-α
(A) and interleukin (IL)-6 (B) mRNA levels were determined by reverse transcription-polymerase chain reaction. Data are mean ± standard
error (n = 3) for three independent experiments. $p < 0.001, compared with control group; *p < 0.05 and ***p < 0.001 compared with LPS-treated group.
SC: Saururus chinensis, LPS: lipopolysaccharide.
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and the results are shown in Figure 5A. DPPH radical
scavenging activities of SC at various concentrations
(0.031, 0.062, 0.125, 0.25, 0.5, 1, and 2 mg/mL) were
38.9 ± 1.5%, 53.2 ± 2.4%, 63.0 ± 3.1%, 77.8 ± 1.6%, 86.8 ±
2.2%, 88.9 ± 1.3%, and 90.8 ± 0.9%, respectively with an
IC50 value of 0.055 ± 0.004 mg/mL. The alkyl radical spin
adduct of 4-POBN/free radicals was generated from
AAPH at 37°C for 30 min, and a decrease in ESR signals
was observed with a dose increases of SC (Figure 5B).
The alkyl radical scavenging activities of SC (025, 0.5,
and 1 mg/mL) were 41.0 ± 1.3%, 56.0 ± 0.5%, and 62.1 ±
5.6%, respectively, with an IC50 value of 0.359 ± 0.07 mg/mL.
These data show that SC possesses significant antioxi-
dant activity.
HPLC fingerprint analysis of SC and the effect of active
constituent on proinflammatory cytokine expression in
LPS stimulated BV-2 microglia
HPLC fingerprinting analysis of SC extract showed sev-
eral peaks indicating a wide mixture of compounds.
Earlier works indicated that SC extract contained poly-
phenolic compounds such as saucerneol D/F, sauchi-
none, manassantin A and B dineolignans and quercetin
(QCT) flavonol glycosides [24-28]. Although the peaks
obtained were below the level of quantification (Figure 6A),
we compared with QCT as reference standard. Based on
the retention time and UV spectrum we identified that
SC extract used in our study contained QCT as one of
the major constituents (Figure 6B). Further, to confirm
the protective effects of QCT on NO release and cyto-
kine expression, indicated concentrations of QCT (1, 5,
and 10 μM) were pretreated to BV-2 cells stimulated
with or without LPS (100 ng/mL). QCT alone at 10 μM
did not exhibit any signs of toxicity in BV-2 cells (datanot shown), however QCT (1, 5 and 10 μM) significantly
and concentration dependently, suppressed LPS-induced
production of NO (Figure 6C) and also attenuated the
increase in IL-6, COX-2 and iNOS expression in a
concentration-dependent manner (Figure 6D).
Discussion
In the present study, we demonstrated that SC extract
pre-treatment regulated the neuroinflammatory events
in LPS-stimulated BV-2 microglial cells in several
aspects. SC extract reduced LPS-stimulated NO pro-
duction in BV-2 microglia cells in a concentration-
dependent manner. SC also suppressed iNOS gene
expression at the mRNA and protein levels. These re-
sults suggest that a significant decrease in NO release
by SC extract is linked with inhibiting upstream iNOS
gene expression.
COX is a key rate-limiting enzyme in the conversion
of arachidonic acid to prostaglandins, which are lipid
metabolites involved in several physiological and patho-
logical processes, including neuroinflammation [29,30].
COX-2 is mainly induced in response to inflammatory
stimuli, which led to the concept that inhibiting COX-2
can reduce inflammatory processes in neurodegenerative
diseases [31]. Several in vivo and in vitro studies have
demonstrated that COX-2 is markedly up regulated in
rodent brain microglia and in BV-2 microglia after LPS
treatment [32-34]. In the current study we determined
whether SC was associated with COX expression in
LPS-stimulated BV-2 microglia cells. As a result, COX-2
mRNA and protein expression was dose-dependently
suppressed by SC treatment (1, 5 and 10 μg/mL). Several
reports have indicated that iNOS and COX-2 are in-
duced in various types of CNS diseases [35,36]. iNOS
and COX-2 are expressed in glial cells of the substantia
Figure 4 Effect of the SC extract on nuclear factor (NF)-κB activity in LPS-stimulated BV-2 microglia. BV-2 microglia cells were seeded at a
density of 1 × 105 cells/well on a 12-well plate. BV-2 microglia cells were stimulated with 100 ng/mL LPS in the absence or presence of the SC
(10 μg/mL) extract that had been added 1 h before stimulation. At 30 min after LPS stimulation, sub-cellular location of the NF-κB p65 subunit
was determined by double-immunofluorescence labeling assay (A). Cells were treated with the indicated dose of SC 30 min before LPS (100 ng/mL)
treatment. Total protein was subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western blotting using anti-IκB-α
and anti-p (phospho)-IκB-α (B). Densitometric analysis of pIκB-α and IκB-α are represented in the panel. Results are expressed as a ratio of phospho/
nonphospo IκB-α/β-actin (C). Data are mean ± standard error (n = 3) of three independent experiments. $p < 0.001, compared with control group;
*p < 0.05 and ***p < 0.001 compared with LPS-treated group. SC: Saururus chinensis, LPS: lipopolysaccharide.
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attenuating the induction of iNOS and COX-2 in acti-
vated microglia could inhibit neuroinflammation.
It was well documented that pro-inflammatory cyto-
kines such as TNF-α, IL-1β, and IL-6 activate iNOS gene
expression in rodent glial and muscle cells [36,38,39].
The likelihood of the involvement of SC in attenuating
such factors is supported by our observations that pro-
inflammatory mediators produced by LPS treatment
such as TNF-α and IL-6 were suppressed by SC in BV-2
microglial cells at mRNA levels. This indicated that SC
extract may be an effective anti-neuroinflammatory
therapeutic agent.
NF-κB is a key transcription factor that is activated by
several cellular signal transduction pathways associated
with the regulation of cell survival and the expression of
proinflammatory cytokines and enzymes such as iNOS,
IL-6 and TNF-α [40,41]. The molecular mechanisms of
NF-κB activation have been well studied, and they involveactivation of a cascade of cytoplasmic proteins and nuclear
translocation of the NF-κB p65 subunit [42,43]. We found
that SC extract attenuated LPS-induced IκB-α degradation
as well as nuclear translocation of p65 in BV-2 microglia,
indicating that SC extract inhibits iNOS and TNF-α gene
expression in microglia and may be involved in the inhib-
ition of NF-κB activation as a possible mechanism.
Previous studies have demonstrated that the specific
iNOS inhibitors reduced NO and act as a potent antioxi-
dant by inhibiting ROS production in LPS-simulated
microglia [44,45]. Reports also showed that several poly-
phenolic compounds with immense antioxidant poten-
tial possess anti-neuroinflammatory properties [46-48].
In light of such reports, in our present study, we found
that the SC significantly scavenged DPPH and alkyl free
radicals exhibiting potent antioxidant actions. The anti-
oxidant potential of SC might partly be responsible in
inhibiting neuroinflammation in LPS-stimulated BV-2
microglial cells.
Figure 6 High performance liquid chromatography (HPLC) fingerprinting of SC extract and the effect of QCT on nitric oxide (NO),
interleukin (IL)-6, cyclooxygenase (COX)-2, and inducible nitric oxide synthase (iNOS) production in LPS-stimulated BV-2 microglia.
HPLC fingerprint analysis of SC (A) and QCT (B). BV-2 cells were incubated for 24 h with LPS (100 ng/mL) in the presence or absence of the
indicated concentrations of SC. The nitrite in the medium was determined by NO assay (C). Several biomarkers were analyzed followed by reverse
transcription-polymerase chain reaction and Western blotting (D). Data are mean ± standard error (n = 3) of three independent experiments. $p < 0.001,
compared with control group; ***p < 0.001 compared with LPS-treated group. SC: Saururus chinensis, LPS: lipopolysaccharide, QCT: quercetin.
Figure 5 Free radical scavenging effects of the SC extract. (A) Left: Electron spin resonance (ESR) spectra of DPPH radical scavenging. Right:
Relationship between the signal intensity of the DPPH radical and various concentrations of SC. (B) Left: ESR spectra of 2-(4-pyridyl-1-oxide)-N-t-
butylnitrone (POBN)-trapped alkyl radical scavenging. Right: Relationship between the signal intensity of the POBN-alkyl radicals and the various
concentrations of SC. SC: Saururus chinensis.
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sauchinone, manassantin A and B dineolignans and quer-
cetin (QCT) flavonol glycosides [24-28]. These compounds
were well reported to possess various biological activities
including anti-inflammatory activities [11,26,49-52]. In our
present study HPLC fingerprint analysis showed that SC
extract contained QCT as one of the major compounds
compared with reference standard.
QCT, a flavonoid polyphenolic compound found in
many natural herbs showed protective effects in both
in vivo and in vitro neurodegenerative models based on
its antioxidant function [46,53-56]. Furthermore, QCT
inhibited gene expression of NO, iNOS, COX-2, and
IL-6 in LPS-stimulated BV-2 cells. Therefore, QCT and
other antioxidant polyphenolic compounds present in the
SC extract might partly contribute and enhance the anti-
neuroinflammatory effects in LPS-stimulated BV-2 cells.
Conclusions
In summary, SC exerted anti-neuroinflammatory actions
by inhibition of major neuroinflammatory mediators and
cytokines in LPS-stimulated BV-2 microglial cells. Mech-
anistic study showed that SC might act by regulating
NF-κB signaling pathways and anti-oxidant defense
mechanisms. The antioxidant potential of SC might also
be responsible for such beneficial effects. Based on the
traditional claims and the present data SC can be poten-
tially used in treating several inflammatory- mediated
neurodegenerative diseases.
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